Amgen biosimilar debut boosted by UnitedHealthcare coverage switch

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 19, 2019 at 12:02 PM.

  1. #1 cafead, Aug 19, 2019 at 12:02 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,932
    Likes Received:
    3
    via UnitedHealthcare, the nation's largest insurer, will preferentially cover lower-cost biosimilar versions of Roche's top-selling cancer drugs Herceptin and Avastin beginning Oct. 1, giving a boost to Amgen's efforts to steal away market share.

    article source
     
    Quote

Reply to Thread